DE60023268D1 - INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alpha - Google Patents
INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alphaInfo
- Publication number
- DE60023268D1 DE60023268D1 DE60023268T DE60023268T DE60023268D1 DE 60023268 D1 DE60023268 D1 DE 60023268D1 DE 60023268 T DE60023268 T DE 60023268T DE 60023268 T DE60023268 T DE 60023268T DE 60023268 D1 DE60023268 D1 DE 60023268D1
- Authority
- DE
- Germany
- Prior art keywords
- puriques
- dependants
- inhibiteurs
- cyclines
- ikb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24122499A | 1999-02-01 | 1999-02-01 | |
US241224 | 1999-02-01 | ||
PCT/US2000/001407 WO2000044750A1 (en) | 1999-02-01 | 2000-01-20 | PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a) |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60023268D1 true DE60023268D1 (de) | 2006-03-02 |
DE60023268T2 DE60023268T2 (de) | 2006-06-01 |
Family
ID=22909777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60023268T Expired - Fee Related DE60023268T2 (de) | 1999-02-01 | 2000-01-20 | INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alpha |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1150982B1 (de) |
JP (1) | JP3681984B2 (de) |
KR (1) | KR20010093308A (de) |
CN (1) | CN1353713A (de) |
AR (1) | AR029612A1 (de) |
AT (1) | ATE306487T1 (de) |
AU (1) | AU2969300A (de) |
BR (1) | BR0007919A (de) |
CA (1) | CA2361518A1 (de) |
CZ (1) | CZ20012765A3 (de) |
DE (1) | DE60023268T2 (de) |
DK (1) | DK1150982T3 (de) |
ES (1) | ES2246829T3 (de) |
GE (1) | GEP20033092B (de) |
HK (1) | HK1044334A1 (de) |
HU (1) | HUP0200535A3 (de) |
IL (2) | IL144675A0 (de) |
MX (1) | MXPA01007851A (de) |
NO (1) | NO327776B1 (de) |
NZ (1) | NZ513371A (de) |
PL (1) | PL350001A1 (de) |
RU (1) | RU2001124352A (de) |
TR (1) | TR200102714T2 (de) |
TW (1) | TW538044B (de) |
UA (1) | UA74142C2 (de) |
WO (1) | WO2000044750A1 (de) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413974B1 (en) | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
US6479487B1 (en) | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
DE69933680T2 (de) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | Pyrimidine verbindungen |
AU5438499A (en) | 1998-08-29 | 2000-03-21 | Astrazeneca Ab | Pyrimidine compounds |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
GB9907658D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Chemical compounds |
GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
IL150062A0 (en) | 1999-12-17 | 2002-12-01 | Ariad Pharma Inc | Proton pump inhibitors |
GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004888D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0007371D0 (en) | 2000-03-28 | 2000-05-17 | Astrazeneca Uk Ltd | Chemical compounds |
GB0016877D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
US6861524B2 (en) | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
GB0113041D0 (en) | 2001-05-30 | 2001-07-18 | Astrazeneca Ab | Chemical compounds |
ATE301123T1 (de) | 2001-06-27 | 2005-08-15 | Cyclacel Ltd | 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten |
US7241890B2 (en) | 2001-10-30 | 2007-07-10 | Conforma Therapeutics Corporation | Purine analogs having HSP90-inhibiting activity |
US20050154046A1 (en) * | 2004-01-12 | 2005-07-14 | Longgui Wang | Methods of treating an inflammatory-related disease |
ES2279903T3 (es) | 2001-12-18 | 2007-09-01 | Cv Therapeutics, Inc. | Antagonistas del receptor a2a de adenosina. |
CA2476431A1 (en) | 2002-02-15 | 2003-08-21 | Cv Therapeutics, Inc. | Coating having polymerized silane derivatives for medical devices |
GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
JP2005524672A (ja) | 2002-03-09 | 2005-08-18 | アストラゼネカ アクチボラグ | Cdk阻害活性を有するイミダゾリル置換ピリミジン誘導体 |
GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0205688D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
GB0219052D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
FR2851248B1 (fr) * | 2003-02-18 | 2005-04-08 | Aventis Pharma Sa | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
US7476670B2 (en) | 2003-02-18 | 2009-01-13 | Aventis Pharma S.A. | Purine derivatives, method for preparing, pharmaceutical compositions and novel use |
GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
KR20060070572A (ko) | 2003-09-18 | 2006-06-23 | 콘포마 세러퓨틱스 코포레이션 | Hsp90-저해제로서의 신규 헤테로시클릭 화합물 |
TW200528101A (en) | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
GB0407723D0 (en) * | 2004-04-05 | 2004-05-12 | Novartis Ag | Organic compounds |
EP1674467A1 (de) * | 2004-12-22 | 2006-06-28 | 4Sc Ag | 2,5- und 2,6-disubstituierte Benzazol-Derivate zur Verwendung als Protein Kinase Inhibitoren |
FR2880626B1 (fr) * | 2005-01-13 | 2008-04-18 | Aventis Pharma Sa | Derives de la purine, compositions les contenant et utilisation |
NZ561939A (en) | 2005-03-30 | 2011-03-31 | Conforma Therapeutics Corp | Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors |
MX2007014297A (es) * | 2005-05-16 | 2008-04-21 | Prometic Biosciences Inc | Derivados de purina y su uso para el tratamiento de enfermedades autoinmunes. |
DE602006010522D1 (de) * | 2005-08-12 | 2009-12-31 | Astellas Pharma Inc | Verfahren zur identifizierung des zielproteins eines wirkstoffs und verfahren zum screening eines therapeutischen wirkstoffs gegen diabetes mittels des zielproteins |
CA2623374A1 (en) | 2005-09-30 | 2007-04-05 | Astrazeneca Ab | Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
GB0706632D0 (en) | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | New purine derivatives |
PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
CZ302122B6 (cs) * | 2009-01-28 | 2010-10-20 | Univerzita Palackého v Olomouci | Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující |
TWI490219B (zh) | 2009-06-29 | 2015-07-01 | Incyte Corp | 作為pi3k抑制劑之嘧啶酮 |
US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
EP2558463A1 (de) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Kondensierte derivate als i3-hemmer |
WO2011163195A1 (en) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
TW201249844A (en) | 2010-12-20 | 2012-12-16 | Incyte Corp | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
WO2012125629A1 (en) | 2011-03-14 | 2012-09-20 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
TWI543980B (zh) | 2011-09-02 | 2016-08-01 | 英塞特控股公司 | 作為pi3k抑制劑之雜環基胺 |
MD20140023A2 (ro) | 2011-09-22 | 2014-06-30 | Pfizer Inc. | Derivaţi de pirolpirimidină şi purină |
US9493464B2 (en) | 2012-02-29 | 2016-11-15 | The Scripps Research Institute | Wee1 degradation inhibitors |
EP2634190A1 (de) * | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazole-Triazin-Derivate als Cyclin-abhängige Kinasen Inhibitoren |
AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
CZ306894B6 (cs) * | 2013-02-08 | 2017-08-30 | Univerzita PalackĂ©ho v Olomouci | 2-Substituované-6-biarylmethylamino-9-cyklopentyl-9H-purinové deriváty, jejich použití jako léčiva a farmaceutické přípravky tyto sloučeniny obsahující |
WO2014134750A1 (zh) * | 2013-03-08 | 2014-09-12 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 2,6,9-三取代嘌呤衍生物及其制备方法与应用 |
EP3020829B1 (de) * | 2013-07-12 | 2021-11-17 | Kyoto University | Pharmazeutische zusammensetzung zur hemmung von abnormalem spleissen als ursache des ausbruchs oder der progression einer genetischen erkrankung |
FR3011240A1 (fr) | 2013-10-01 | 2015-04-03 | Centre Nat Rech Scient | Inhibiteurs de 5'-nucleotidases et leurs utilisations therapeutiques |
US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
LT3831833T (lt) | 2015-02-27 | 2023-02-27 | Incyte Holdings Corporation | Pi3k inhibitoriaus gamybos būdai |
US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
CN107235981B (zh) * | 2017-05-25 | 2019-10-25 | 北京工业大学 | 低氧激活o6-苄基-2-硝基嘌呤衍生物及制法和应用 |
CN107903274A (zh) * | 2017-12-28 | 2018-04-13 | 窦玉玲 | 一种胺类化合物及其在抗肿瘤药物中的应用 |
CN110256436B (zh) * | 2019-06-27 | 2020-06-09 | 南京雷正医药科技有限公司 | 作为Trk激酶抑制剂的嘌呤类化合物 |
WO2022206795A1 (en) * | 2021-04-02 | 2022-10-06 | Taizhou Eoc Pharma Co., Ltd. | A cyclin-dependent kinase inhibitor |
WO2023046128A1 (en) * | 2021-09-27 | 2023-03-30 | Taizhou Eoc Pharma Co., Ltd. | A cyclin-dependent kinase inhibitor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
AU735127B2 (en) * | 1997-08-07 | 2001-06-28 | Regents Of The University Of California, The | Purine inhibitor of protein kinases, G proteins and polymerases |
-
2000
- 2000-01-20 CN CN00805567A patent/CN1353713A/zh active Pending
- 2000-01-20 IL IL14467500A patent/IL144675A0/xx active IP Right Grant
- 2000-01-20 KR KR1020017009707A patent/KR20010093308A/ko not_active Application Discontinuation
- 2000-01-20 ES ES00908325T patent/ES2246829T3/es not_active Expired - Lifetime
- 2000-01-20 PL PL00350001A patent/PL350001A1/xx not_active Application Discontinuation
- 2000-01-20 CZ CZ20012765A patent/CZ20012765A3/cs unknown
- 2000-01-20 HU HU0200535A patent/HUP0200535A3/hu unknown
- 2000-01-20 JP JP2000596006A patent/JP3681984B2/ja not_active Expired - Fee Related
- 2000-01-20 MX MXPA01007851A patent/MXPA01007851A/es not_active IP Right Cessation
- 2000-01-20 RU RU2001124352/04A patent/RU2001124352A/ru unknown
- 2000-01-20 DE DE60023268T patent/DE60023268T2/de not_active Expired - Fee Related
- 2000-01-20 WO PCT/US2000/001407 patent/WO2000044750A1/en active IP Right Grant
- 2000-01-20 AU AU29693/00A patent/AU2969300A/en not_active Abandoned
- 2000-01-20 EP EP00908325A patent/EP1150982B1/de not_active Expired - Lifetime
- 2000-01-20 TR TR2001/02714T patent/TR200102714T2/xx unknown
- 2000-01-20 AT AT00908325T patent/ATE306487T1/de not_active IP Right Cessation
- 2000-01-20 BR BR0007919-7A patent/BR0007919A/pt active Pending
- 2000-01-20 NZ NZ513371A patent/NZ513371A/en unknown
- 2000-01-20 CA CA002361518A patent/CA2361518A1/en not_active Abandoned
- 2000-01-20 DK DK00908325T patent/DK1150982T3/da active
- 2000-01-20 UA UA2001085511A patent/UA74142C2/uk unknown
- 2000-01-20 GE GEAP20006078A patent/GEP20033092B/en unknown
- 2000-01-31 AR ARP000100411A patent/AR029612A1/es active IP Right Grant
- 2000-04-19 TW TW089101723A patent/TW538044B/zh not_active IP Right Cessation
-
2001
- 2001-07-31 NO NO20013751A patent/NO327776B1/no not_active IP Right Cessation
- 2001-07-31 IL IL144675A patent/IL144675A/en not_active IP Right Cessation
-
2002
- 2002-08-10 HK HK02105857.9A patent/HK1044334A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
RU2001124352A (ru) | 2004-02-20 |
EP1150982A1 (de) | 2001-11-07 |
UA74142C2 (uk) | 2005-11-15 |
CA2361518A1 (en) | 2000-08-03 |
GEP20033092B (en) | 2003-10-27 |
IL144675A (en) | 2008-11-26 |
HUP0200535A2 (hu) | 2002-07-29 |
TR200102714T2 (tr) | 2002-01-21 |
EP1150982B1 (de) | 2005-10-12 |
NZ513371A (en) | 2003-08-29 |
PL350001A1 (en) | 2002-10-21 |
IL144675A0 (en) | 2002-05-23 |
JP3681984B2 (ja) | 2005-08-10 |
CZ20012765A3 (cs) | 2002-08-14 |
NO20013751D0 (no) | 2001-07-31 |
ATE306487T1 (de) | 2005-10-15 |
NO327776B1 (no) | 2009-09-21 |
HUP0200535A3 (en) | 2002-11-28 |
ES2246829T3 (es) | 2006-03-01 |
MXPA01007851A (es) | 2003-06-04 |
JP2002535405A (ja) | 2002-10-22 |
KR20010093308A (ko) | 2001-10-27 |
AR029612A1 (es) | 2003-07-10 |
HK1044334A1 (zh) | 2002-10-18 |
DK1150982T3 (da) | 2005-12-27 |
WO2000044750A1 (en) | 2000-08-03 |
BR0007919A (pt) | 2002-04-09 |
NO20013751L (no) | 2001-09-27 |
AU2969300A (en) | 2000-08-18 |
TW538044B (en) | 2003-06-21 |
DE60023268T2 (de) | 2006-06-01 |
CN1353713A (zh) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60023268D1 (de) | INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alpha | |
FR20C1039I2 (fr) | Derives de l'uk-2a | |
MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
NO20021382D0 (no) | Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser | |
IS2325B (is) | Örgerðar samsetningar epleróns | |
ID25792A (id) | Antibodi-antibodi terhadap cd40 manusia | |
ID24372A (id) | SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs | |
PT1109558E (pt) | Formulacoes de ranolazina de libertacao controlada | |
NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
EE200200571A (et) | Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
NO20015542L (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
NO20010490L (no) | Inhibisjon av ''graft-versus-host''-sykdom | |
FR2818979B1 (fr) | Procede de preparation d'imidaclopride | |
DE69906921D1 (de) | Erweiterung des Farbtonumfangs | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
EE200200577A (et) | Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
NO20013795D0 (no) | Regulering av anestesi | |
EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
FR2791876B1 (fr) | Parure de lit | |
ID30381A (id) | Penggunaan arilalkanoilpiridazina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |